ライフサイエンスコーパス: postoperative bleeding

1 r level III, required reoperation to control postoperative bleeding).

2 h-free operated sides, 4.7% (n = 6) suffered postoperative bleeding.

3 gents are not associated with an increase in postoperative bleeding.

4 effects of heparin and to limit the risk for postoperative bleeding.

5 tion II (APACHE II) scores, reoperation, and postoperative bleeding.

6 ry is controversial because of concern about postoperative bleeding.

7 No patient experienced postoperative bleeding.

8 ly increased incidence of re-exploration for postoperative bleeding.

9 n is associated with a greater likelihood of postoperative bleeding.

10 afting (CABG) is associated with significant postoperative bleeding.

11 One mitral patient had postoperative bleeding.

12 al procedure; the most common indication was postoperative bleeding.

13 use of Tachosil(R) seems to help preventing postoperative bleeding.

14 ent protective effect of obesity on risks of postoperative bleeding.

15 to the emergency department or hospital with postoperative bleeding.

16 boratory and discharge reports in regards to postoperative bleeding.

17 were predominantly severe intraoperative and postoperative bleeding (136 [3.8%] of 3612 mothers).

18 Postoperative bleeding (17%), septic shock (16%), pulmon

19 nificant, rates of adverse events, including postoperative bleeding (20.6% for HCD vs 8.8% for petrol

20 lowed by excessive pain (4.1%), and moderate postoperative bleeding (3.5%).

21 collections (9.3%), pleural effusion (8.3%), postoperative bleeding (5.6%), and other major complicat

22 No significant differences were observed for postoperative bleeding and analgesic consumption at any

23 dial infarction, stent thrombosis, peri- and postoperative bleeding and death.

24 spirin before CABG is associated with higher postoperative bleeding and morbidity.

25 O are at high risk of major perioperative or postoperative bleeding and postoperative complications,

26 metry, to screen out patients at low risk of postoperative bleeding and then guide individualized FC

27 There was no difference with respect to postoperative bleeding and transfusion requirements in t

28 ve period to the end of postoperative day 1, postoperative bleeding, and adverse events.

29 ostoperative cerebrovascular accident (CVA), postoperative bleeding, and sternal wound infection, wer

30 SUMMARY BACKGROUND DATA: Balancing risks of postoperative bleeding associated with continued clopido

31 mized clinical trials found no difference in postoperative bleeding between the groups taking ketorol

32 There was minimal postoperative bleeding, cerebral vascular accidents, or

33 The primary outcome was postoperative bleeding (chest tube output) from the init

34 gth of stay and disposition after discharge, postoperative bleeding, cosmesis, and postoperative pain

35 nly 1.0 (-2.5 to 4.0) cm in patients with no postoperative bleeding (difference in the medians, 4.0 c

36 In this cohort study, of the major postoperative bleeding events in the first 30 days, more

37 There were more postoperative bleeding events with PG.

38 Less postoperative bleeding, fewer blood transfusions, better

39 operative acute pancreatitis and one case of postoperative bleeding from the anastomotic suture line

40 m) demonstrated clinically significant early postoperative bleeding (>10 mL/kg per 4 hours).

41 gery or procedure in 11.7%, and high risk of postoperative bleeding in 10.6%.

42 e (level I, self-reported or parent-reported postoperative bleeding; level II, required inpatient adm

43 icantly different between the groups whereas postoperative bleeding, nerve injury, respiratory and re

44 ose of ketorolac does not result in abnormal postoperative bleeding or alter renal function.

45 ilure, new renal failure requiring dialysis, postoperative bleeding or tamponade requiring reoperatio

46 ; level II, required inpatient admission for postoperative bleeding; or level III, required reoperati

47 ), incidence of reoperations (P = 1.000), or postoperative bleeding (P = 0.343).

48 Postoperative bleeding, pain, discomfort, and analgesic

49 Postoperative bleeding rates were lower in patients pres

50 Postoperative bleeding remains one of the most frequent,

51 Four episodes of postoperative bleeding requiring exploration occurred in

52 ak necessitating biliary reconstruction, and postoperative bleeding requiring re-exploration.

53 The incidence of postoperative bleeding requiring reexploration and the i

54 Postoperative bleeding requiring transfusion was not ver

55 No association between postoperative bleeding risk and Caprini score was identi

56 Our study aimed to estimate postoperative bleeding risk in older adults taking clopi

57 ary embolism, shock, intestinal obstruction, postoperative bleeding, staple line leak, and severe mal

58 bleeding after cardiac surgery and in other postoperative bleeding states.

59 Major adverse events included postoperative bleeding, stroke, right heart failure, and

60 methods provide better hemostasis and lower postoperative bleeding to best manage men with BPH on ch

61 quency, and the most common complication was postoperative bleeding/transfusion.

62 There were no significant differences in postoperative bleeding, transfusions, or adverse events.

63 on major adverse cardiovascular outcomes and postoperative bleeding using the Cleveland Clinic Cardio

64 Effectiveness measures included postoperative bleeding volume (first 24 hours post-ICU a

65 rocedure (OR, 1.14 [95% CI, 0.82-1.59]), but postoperative bleeding was more frequent in patients rec

66 or the need for surgical re-exploration for postoperative bleeding was recorded.

67 On the other hand, rates of postoperative bleeding were significantly lower in the o